Comparison of once daily versus twice daily olmesartan in patients with chronic kidney disease

BACKGROUND: The effects of olmesartan (OLM) on blood pressure and kidney function in Japanese patients with chronic kidney disease (CKD) were compared between 20 mg twice daily (BID) and 40 mg once daily (QD) treatments. METHODS: The subjects were Japanese CKD patients with concurrent hypertension w...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Sakai, Yukinao, Suzuki, Anna, Mugishima, Koji, Sumi, Yuichiro, Otsuka, Yusuke, Otsuka, Tomoyuki, Ohno, Dai, Murasawa, Tsuneo, Tsuruoka, Shuichi
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2013
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3797633/
https://ncbi.nlm.nih.gov/pubmed/24143121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S52905
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares